Xianjie Cheng, Birong Liu, Hong Lou, Fei Guo, Qiangsheng Xiao. A prognostic model for basal-like breast cancer based on beta-alanine metabolism genes: EHHADH as a potential biomarker and target for drug screening. // Genes & Genomics. – 2025. – DOI: 10.1007/s13258-025-01674-3. – URL: https://doi.org/10.1007/s13258-025-01674-3
Xianjie Cheng, Birong Liu, Hong Lou, Fei Guo, & Qiangsheng Xiao (2025). A prognostic model for basal-like breast cancer based on beta-alanine metabolism genes: EHHADH as a potential biomarker and target for drug screening. Genes & Genomics. https://doi.org/10.1007/s13258-025-01674-3
Xianjie Cheng, et al. “A prognostic model for basal-like breast cancer based on beta-alanine metabolism genes: EHHADH as a potential biomarker and target for drug screening.” Genes & Genomics, 2025. doi:10.1007/s13258-025-01674-3.
@article{Cheng2025,
title = {A prognostic model for basal-like breast cancer based on beta-alanine metabolism genes: EHHADH as a potential biomarker and target for drug screening},
author = {Cheng, Xianjie and Liu, Birong and Lou, Hong and Guo, Fei and Xiao, Qiangsheng},
journal = {Genes \& Genomics},
year = {2025},
doi = {10.1007/s13258-025-01674-3},
url = {https://doi.org/10.1007/s13258-025-01674-3}
}